Mometasone Furoate Nasal Spray for Treatment of Nasal Polyposis After Surgery (Study P03218)
Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
This study was conducted to evaluate the effectiveness of mometasone nasal spray in
preventing polyp relapse/symptom worsening in patients after surgical treatment of nasal
polyps. Patients who met Screening eligibility underwent endoscopic sino-nasal surgery (FESS)
on visit 2. Mometasone nasal spray or placebo was started about 2 weeks after surgery and
continued for up to 24 weeks or until relapse.